134 related articles for article (PubMed ID: 14640894)
21. Effects of nitric oxide synthase inhibitors on bone formation in rats.
Turner CH; Owan I; Jacob DS; McClintock R; Peacock M
Bone; 1997 Dec; 21(6):487-90. PubMed ID: 9430237
[TBL] [Abstract][Full Text] [Related]
22. Circulating levels and bone contents of bone gamma-carboxyglutamic acid-containing protein in rat models of non-insulin-dependent diabetes mellitus.
Takeshita N; Ishida H; Yamamoto T; Koh G; Kurose T; Tsuji K; Okamoto Y; Ikeda H; Seino Y
Acta Endocrinol (Copenh); 1993 Jan; 128(1):69-73. PubMed ID: 8447197
[TBL] [Abstract][Full Text] [Related]
23. Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin.
Bagi Z; Koller A
J Vasc Res; 2003; 40(1):47-57. PubMed ID: 12644725
[TBL] [Abstract][Full Text] [Related]
24. Circulating levels of tartrate-resistant acid phosphatase in rat models of non-insulin-dependent diabetes mellitus.
Suzuki K; Ishida H; Takeshita N; Taguchi Y; Sugimoto C; Nosaka K; Seino Y
J Diabetes Complications; 1998; 12(3):176-80. PubMed ID: 9618074
[TBL] [Abstract][Full Text] [Related]
25. L-arginine prevents bone loss and bone collagen breakdown in cyclosporin A-treated rats.
Fiore CE; Pennisi P; Cutuli VM; Prato A; Messina R; Clementi G
Eur J Pharmacol; 2000 Nov; 408(3):323-6. PubMed ID: 11090650
[TBL] [Abstract][Full Text] [Related]
26. Effect of pancreas transplantation on decreased levels of circulating bone gamma-carboxyglutamic acid-containing protein and osteopenia in rats with streptozotocin-induced diabetes.
Ishida H; Seino Y; Takeshita N; Kurose T; Tsuji K; Okamoto Y; Someya Y; Hara K; Akiyama Y; Imura H
Acta Endocrinol (Copenh); 1992 Jul; 127(1):81-5. PubMed ID: 1387756
[TBL] [Abstract][Full Text] [Related]
27. Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats.
Hie M; Shimono M; Fujii K; Tsukamoto I
Bone; 2007 Dec; 41(6):1045-50. PubMed ID: 17916452
[TBL] [Abstract][Full Text] [Related]
28. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat.
Lindsay RM; Peet RS; Wilkie GS; Rossiter SP; Smith W; Baird JD; Williams BC
Br J Pharmacol; 1997 Jan; 120(1):1-6. PubMed ID: 9117082
[TBL] [Abstract][Full Text] [Related]
29. Influence of nitric oxide synthase and kinin antagonists on metabolic parameters in chronic streptozotocin-induced diabetes mellitus.
González E; Roselló-Catafau J; Xaus C; Jawerbaum A; Novaro V; Gómez G; Gelpí E; Gimeno MA
Prostaglandins; 1997 May; 53(5):321-36. PubMed ID: 9247972
[TBL] [Abstract][Full Text] [Related]
30. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
Majithiya JB; Parmar AN; Trivedi CJ; Balaraman R
Vascul Pharmacol; 2005 Oct; 43(4):260-6. PubMed ID: 16168716
[TBL] [Abstract][Full Text] [Related]
31. Impaired duodenal bicarbonate secretion in diabetic rats. Salutary effect of nitric oxide synthase inhibitor.
Takeuchi K; Hirata T; Korolkiewicz R; Sugawa Y; Kubomi M
J Physiol Paris; 1997; 91(3-5):235-40. PubMed ID: 9403801
[TBL] [Abstract][Full Text] [Related]
32. Failure of the nitric oxide synthase inhibitor to stimulate duodenal bicarbonate secretion in streptozotocin-diabetic rats.
Takehara K; Tashima K; Kato S; Takeuchi K
Life Sci; 1997; 60(17):1505-14. PubMed ID: 9126871
[TBL] [Abstract][Full Text] [Related]
33. An in vivo experimental study on osteopenia in diabetic rats.
Musumeci G; Loreto C; Clementi G; Fiore CE; Martinez G
Acta Histochem; 2011 Oct; 113(6):619-25. PubMed ID: 20696468
[TBL] [Abstract][Full Text] [Related]
34. Increased bone resorption may play a crucial role in the occurrence of osteopenia in patients with type 2 diabetes: Possible involvement of accelerated polyol pathway in its pathogenesis.
Takizawa M; Suzuki K; Matsubayashi T; Kikuyama M; Suzuki H; Takahashi K; Katsuta H; Mitsuhashi J; Nishida S; Yamaguchi S; Yoshimoto K; Itagaki E; Ishida H
Diabetes Res Clin Pract; 2008 Oct; 82(1):119-26. PubMed ID: 18774197
[TBL] [Abstract][Full Text] [Related]
35. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
[TBL] [Abstract][Full Text] [Related]
36. Effects of streptozotocin-induced diabetes mellitus on some bone turnover markers in the vertebrae of ovary-intact and ovariectomized adult rats.
Gopalakrishnan V; Arunakaran J; Aruldhas MM; Srinivasan N
Biochem Cell Biol; 2006 Oct; 84(5):728-36. PubMed ID: 17167536
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy.
Veelken R; Hilgers KF; Hartner A; Haas A; Böhmer KP; Sterzel RB
J Am Soc Nephrol; 2000 Jan; 11(1):71-79. PubMed ID: 10616842
[TBL] [Abstract][Full Text] [Related]
38. Effects of capsaicin-induced sensory denervation on bone metabolism in adult rats.
Ding Y; Arai M; Kondo H; Togari A
Bone; 2010 Jun; 46(6):1591-6. PubMed ID: 20193788
[TBL] [Abstract][Full Text] [Related]
39. Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats.
Bain S; Ramamurthy NS; Impeduglia T; Scolman S; Golub LM; Rubin C
Bone; 1997 Aug; 21(2):147-53. PubMed ID: 9267690
[TBL] [Abstract][Full Text] [Related]
40. Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopenia.
Hadjidakis D; Lempert UG; Minne HW; Ziegler R
Horm Metab Res; 1993 Feb; 25(2):77-81. PubMed ID: 8458612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
